Kezar Life Sciences, Inc. (KZR) Tops Q1 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance